Effects of metformin in adolescents with polycystic ovary syndrome undertaking lifestyle therapy: a pilot randomized double-blind study  Gwinnett Ladson,

Slides:



Advertisements
Similar presentations
J.C. Trussell, M.D., Allen R. Kunselman, M.A., Richard S. Legro, M.D. 
Advertisements

Effect of sibutramine on weight reduction in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial  Åsa Lindholm,
Clinically significant and sustained weight loss is achievable in obese women with polycystic ovary syndrome followed in a regular medical practice  Lysanne.
Andrew J. Krentz, M.D., Elizabeth Barrett-Connor, M.D. 
Short-term therapy with combination dipeptidyl peptidase-4 inhibitor saxagliptin/metformin extended release (XR) is superior to saxagliptin or metformin.
Yuqian Cui, M. D. , Ph. D. , Yuhua Shi, M. D. , Ph. D. , Linlin Cui, M
Low-dose oral contraceptive pill for dysmenorrhea associated with endometriosis: a placebo-controlled, double-blind, randomized trial  Tasuku Harada,
Gaps in knowledge among physicians regarding diagnostic criteria and management of polycystic ovary syndrome  Anuja Dokras, M.D., Ph.D., Shailly Saini,
The effect of cinnamon extract on insulin resistance parameters in polycystic ovary syndrome: a pilot study  Jeff G. Wang, M.D., Richard A. Anderson,
Increased prevalence of anxiety symptoms in women with polycystic ovary syndrome: systematic review and meta-analysis  Anuja Dokras, M.D., Ph.D., Shari.
Comparison of hormonal and metabolic markers after a high-fat, Western meal versus a low-fat, high-fiber meal in women with polycystic ovary syndrome 
Androgen and lipid profiles in adolescents with polycystic ovary syndrome who were treated with two forms of combined oral contraceptives  George Mastorakos,
Michal Youngster, M. D. , Valerie L. Ward, M. D. , M. P. H. , Emily A
Clinical application of oocyte vitrification: a systematic review and meta-analysis of randomized controlled trials  Ana Cobo, Ph.D., César Diaz, M.D. 
Gaps in knowledge among physicians regarding diagnostic criteria and management of polycystic ovary syndrome  Anuja Dokras, M.D., Ph.D., Shailly Saini,
Possible metformin effect on adrenal androgens during pretreatment and IVF cycle in women with polycystic ovary syndrome  Sigrun B. Kjøtrød, M.D., Arne.
Can an educational DVD improve the acceptability of elective single embryo transfer? A randomized controlled study  Nicole Hope, M.B., B.S., Hon., Luk.
Mammographic breast density, hormones, and growth factors during continuous combined hormone therapy  Peter Conner, M.D., Gunilla Svane, M.D., Ph.D.,
Is the addition of metformin efficacious in the treatment of clomiphene citrate-resistant patients with polycystic ovary syndrome? A structured literature.
Obesity, weight loss, and the polycystic ovary syndrome: effect of treatment with diet and orlistat for 24 weeks on insulin resistance and androgen levels 
A randomized trial of the effects of two types of short-term hypocaloric diets on weight loss in women with polycystic ovary syndrome  Kelly Stamets,
Follicle-stimulating hormone administered at the time of human chorionic gonadotropin trigger improves oocyte developmental competence in in vitro fertilization.
A randomized, controlled, pilot trial on the effect of dehydroepiandrosterone on ovarian response markers, ovarian response, and in vitro fertilization.
Evaluation of an ultra-low-dose oral contraceptive for dysmenorrhea: a placebo- controlled, double-blind, randomized trial  Tasuku Harada, M.D., Mikio.
Levonorgestrel effects on serum androgens, sex hormone–binding globulin levels, hair shaft diameter, and sexual function  George Kovalevsky, M.D., Susan.
Efficacy of metformin therapy in adolescent girls with androgen excess: relation to sex hormone–binding globulin and androgen receptor polymorphisms 
Randomized, controlled pilot trial of natural versus hormone replacement therapy cycles in frozen embryo replacement in vitro fertilization  Ginny Mounce,
Surgical treatment of endometriosis: a prospective randomized double-blinded trial comparing excision and ablation  Martin Healey, M.D., W. Catarina Ang,
Functional neuroimaging of emotional processing in women with polycystic ovary syndrome: a case-control pilot study  Courtney A. Marsh, M.D., M.P.H.,
Improvement in quality-of-life questionnaire measures in obese adolescent females with polycystic ovary syndrome treated with lifestyle changes and oral.
Comparison of effects of 3 mg drospirenone plus 20 μg ethinyl estradiol alone or combined with metformin or cyproterone acetate on classic metabolic cardiovascular.
Letrozole versus combined metformin and clomiphene citrate for ovulation induction in clomiphene-resistant women with polycystic ovary syndrome: a randomized.
Adolescent Caucasian mothers have reduced adult hip bone density
Serum soluble leptin receptor levels and free leptin index in women with polycystic ovary syndrome: relationship to insulin resistance and androgens 
Hysteroscopic local anesthetic intrauterine cornual block in office endometrial ablation: a randomized controlled trial  Vinod Kumar, Ph.D., Konstantinos.
The Pregnancy in Polycystic Ovary Syndrome II study: baseline characteristics and effects of obesity from a multicenter randomized clinical trial  Richard.
Does metformin affect the ovarian response to gonadotropins for in vitro fertilization treatment in patients with polycystic ovary syndrome and reduced.
Use of combined hormonal contraceptives for the treatment of endometriosis-related pain: a systematic review of the evidence  Jeffrey T. Jensen, M.D.,
The effects of metformin with lifestyle therapy in polycystic ovary syndrome: a randomized double-blind study  Gwinnett Ladson, M.D., William C. Dodson,
From partner's desk to iPad
Pretreatment with estrogen does not affect IVF-ICSI cycle outcome compared with no pretreatment in GnRH antagonist protocol: a prospective randomized.
Increased secretion of amylin in women with polycystic ovary syndrome
Effects of metformin and rosiglitazone, alone and in combination, in nonobese women with polycystic ovary syndrome and normal indices of insulin sensitivity 
Prevalence of polycystic ovary syndrome in adolescents
Comparison of clomiphene citrate, metformin, or the combination of both for first-line ovulation induction, achievement of pregnancy, and live birth in.
Cancer risk among infertile women with androgen excess or menstrual disorders (including polycystic ovary syndrome)  Louise A. Brinton, Ph.D., Kamran.
Metformin reduces serum müllerian-inhibiting substance levels in women with polycystic ovary syndrome after protracted treatment  Richard Fleming, Ph.D.,
Simvastatin improves biochemical parameters in women with polycystic ovary syndrome: results of a prospective, randomized trial  Antoni J. Duleba, M.D.,
Diminished paternity and gonadal function with increasing obesity in men  Eric M. Pauli, M.D., Richard S. Legro, M.D., Laurence M. Demers, Ph.D., Allen.
Effects of treatment with testosterone alone or in combination with estrogen on insulin sensitivity in postmenopausal women  Hong Zang, M.D., Kjell Carlström,
Impact of laparoscopic ovarian drilling on anti-Müllerian hormone levels and ovarian stromal blood flow using three-dimensional power Doppler in women.
A prospective, randomized, double-blind, placebo-controlled trial of multimodal intraoperative analgesia for laparoscopic excision of endometriosis  Michael.
Pregnancy outcome in infertile patients with polycystic ovary syndrome who were treated with metformin  Samuel S. Thatcher, M.D., Ph.D., Elizabeth M.
A randomized controlled pilot study of acupuncture for postmenopausal hot flashes: effect on nocturnal hot flashes and sleep quality  Mary I. Huang, M.S.,
The Pregnancy in Polycystic Ovary Syndrome Study: baseline characteristics of the randomized cohort including racial effects  Richard S. Legro, M.D.,
A randomized clinical trial to determine optimal infertility treatment in older couples: the Forty and Over Treatment Trial (FORT-T)  Marlene B. Goldman,
Paolo Moghetti, M.D.  Fertility and Sterility 
Metformin effects on ovarian ultrasound appearance and steroidogenic function in normal-weight normoinsulinemic women with polycystic ovary syndrome:
Comparison of clomiphene citrate, metformin, or the combination of both for first-line ovulation induction and achievement of pregnancy in 154 women with.
Metformin therapy throughout pregnancy reduces the development of gestational diabetes in women with polycystic ovary syndrome  C.J Glueck, M.D., Ping.
The reproductive and metabolic effect of rosiglitazone on Chinese women with polycystic ovarian syndrome—a double-blind randomized placebo-controlled.
Proteomic biomarkers for ovarian cancer risk in women with polycystic ovary syndrome: a systematic review and biomarker database integration  Nicolas.
Janet S. Carpenter, Ph. D. , R. N. , Katherine A. Guthrie, Ph. D
Endothelial function and insulin resistance in polycystic ovary syndrome: the effects of medical therapy  Helena J. Teede, Ph.D., Caroline Meyer, Ph.D.,
Prevention of menstrual migraine with perimenstrual transdermal 17-β-estradiol: a randomized, placebo-controlled, double-blind crossover study  Anna Almén-Christensson,
Thomas M Price, M.D., Susan Allen, R.N., G.Vernon Pegram, M.D. 
A randomized, 48-week, placebo-controlled trial of intensive lifestyle modification and/or metformin therapy in overweight women with polycystic ovary.
Randomized, controlled pilot trial of natural versus hormone replacement therapy cycles in frozen embryo replacement in vitro fertilization  Ginny Mounce,
Adolescent girls with polycystic ovary syndrome showing different phenotypes have a different metabolic profile associated with increasing androgen levels 
Diabetes mellitus and insulin resistance in mothers, fathers, sisters, and brothers of women with polycystic ovary syndrome: a systematic review and meta-analysis 
Presentation transcript:

Effects of metformin in adolescents with polycystic ovary syndrome undertaking lifestyle therapy: a pilot randomized double-blind study  Gwinnett Ladson, M.D., William C. Dodson, M.D., Stephanie D. Sweet, M.D., Anthony E. Archibong, Ph.D., Allen R. Kunselman, M.A., Laurence M. Demers, Ph.D., Peter A. Lee, M.D., Ph.D., Nancy I. Williams, Sc.D., Ponjola Coney, M.D., Richard S. Legro, M.D.  Fertility and Sterility  Volume 95, Issue 8, Pages 2595-2598.e6 (June 2011) DOI: 10.1016/j.fertnstert.2011.05.048 Copyright © 2011 Terms and Conditions

Figure 1 (A) Changes in total serum testosterone, (B) Free Androgen Index (FAI), (C) acne lesion count, and (D) weight over 6 months by treatment arm. Metformin = combined metformin and lifestyle; Placebo = lifestyle and metformin. ∗P<.05 for a within-group change from baseline, † P<.05 for a between-group comparison at a given month. Fertility and Sterility 2011 95, 2595-2598.e6DOI: (10.1016/j.fertnstert.2011.05.048) Copyright © 2011 Terms and Conditions

Supplemental Figure 1 Flow chart of study participants in the trial. Fertility and Sterility 2011 95, 2595-2598.e6DOI: (10.1016/j.fertnstert.2011.05.048) Copyright © 2011 Terms and Conditions